- Home
- GH vs CLSK Comparison
GH vs CLSK Comparison
Compare GH & CLSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- CLSK
- Stock Information
- Founded
- GH 2011
- CLSK 1987
- Country
- GH United States
- CLSK United States
- Employees
- GH N/A
- CLSK N/A
- Industry
- GH Medical Specialities
- CLSK Finance: Consumer Services
- Sector
- GH Health Care
- CLSK Finance
- Exchange
- GH Nasdaq
- CLSK Nasdaq
- Market Cap
- GH 2.7B
- CLSK 3.0B
- IPO Year
- GH 2018
- CLSK N/A
- Fundamental
- Price
- GH $30.98
- CLSK $12.97
- Analyst Decision
- GH Strong Buy
- CLSK Strong Buy
- Analyst Count
- GH 15
- CLSK 7
- Target Price
- GH $39.93
- CLSK $21.21
- AVG Volume (30 Days)
- GH 2.2M
- CLSK 37.6M
- Earning Date
- GH 11-06-2024
- CLSK 12-03-2024
- Dividend Yield
- GH N/A
- CLSK N/A
- EPS Growth
- GH N/A
- CLSK N/A
- EPS
- GH N/A
- CLSK N/A
- Revenue
- GH $692,256,000.00
- CLSK $342,213,000.00
- Revenue This Year
- GH $31.00
- CLSK $140.64
- Revenue Next Year
- GH $17.55
- CLSK $96.42
- P/E Ratio
- GH N/A
- CLSK N/A
- Revenue Growth
- GH 29.20
- CLSK 140.89
- 52 Week Low
- GH $15.81
- CLSK $4.87
- 52 Week High
- GH $37.04
- CLSK $24.72
- Technical
- Relative Strength Index (RSI)
- GH 70.13
- CLSK 50.33
- Support Level
- GH $28.45
- CLSK $12.84
- Resistance Level
- GH $32.26
- CLSK $14.57
- Average True Range (ATR)
- GH 1.70
- CLSK 1.60
- MACD
- GH 0.39
- CLSK -0.14
- Stochastic Oscillator
- GH 75.19
- CLSK 39.48
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About CLSK CleanSpark Inc.
Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.